Back to News
Feb 27, 2026 12:40 PM

What's Going On With MannKind Stock Friday?

MannKind Corporation (NASDAQ:MNKD) reported its fourth-quarter and full-year 2025 financial results on Friday.

The company reported fourth-quarter adjusted earnings per share of one cent, in line with the Street view. Quarterly sales of $111.955 million outpaced the Street view of $97.604 million.

MannKind reported total revenues for the fourth quarter and full year 2025 rose due to increases in revenue from royalties, collaborations, and commercial product sales.

The CEO highlighted the addition of Furoscix as a significant boost to their cardiometabolic franchise, while Afrezza and UT-related revenues continue to show sustained growth.

MannKind exited the quarter with cash and equivalents worth $74.882 million.

Technical Analysis

The stock is currently trading 9.8% below its 20-day ...